Clinical Trials Logo

Pulmonary Infections clinical trials

View clinical trials related to Pulmonary Infections.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01519661 Completed - Clinical trials for Pulmonary Infections

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Start date: January 2012
Phase: Phase 4
Study type: Interventional

This study assessed the long term safety data for the use of tobramycin inhalation powder in patients suffering from cystic fibrosis who have a chronic pulmonary infection with Pseudomonas aeruginosa.

NCT ID: NCT01356147 Completed - Clinical trials for Pulmonary Infections

Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)

PVAIN
Start date: May 2011
Phase: Phase 4
Study type: Interventional

To evaluate the effect of Dornase alfa on preterm and late preterm neonates with ventilator associated pulmonary infections. Dornase alfa has been effective in the treatment of pulmonary infections in patients with cystic fibrosis by aiding mucus clearance. The bacteria causing pulmonary infections in cystic fibrosis patients is similar to those infecting preterm infants. The investigators expect that dornase alfa therapy will improve recovery from ventilator associated pulmonary infections in preterm infants.

NCT ID: NCT01069705 Completed - Clinical trials for Pseudomonas Aeruginosa

Second Open Label Extension to Bridging Study CTBM100C2303

Start date: February 12, 2010
Phase: Phase 3
Study type: Interventional

This was an open-label, single arm (uncontrolled) study in participants suffering from cystic fibrosis, who have completed their study participation in CTBM100C2303 and extension study one CTBM100C2303E1 (all visits), who were proven infected with Pseudomonas aeruginosa at enrollment into CTBM100C2303.